Keynote and plenary speakers

EVER Lecture - delivered by the Past President

Traditional the EVER lecture is given by the past-president. This year the EVER lecture will be given by Prof. Aki Kawasaki, Lausanne, Switzerland.
Professor Aki Kawasaki is an associate professor at the Hôpital Ophtalmique Jules Gonin, Lausanne, Switzerland and Director of the Laboratory of Pupillometry, Hôpital Ophtalmique Jules Gonin. She is Past-President of the European Association for Vision and Eye Research, member of the Advisory Board at the International Council of Ophthalmology, editor of Frontiers in Neuro-Ophthalmology, and section editor for Current Neurology and Neuroscience Report. She serves on the Board of EVER, Acta Ophtalmologica, Scientific Report and the Neuro-Ophthalmic Virtual Education Library (NOVEL). Professor Kawasaki's research is focused in the domain of the pupil as a biomarker of retinal light sensitivity in health and disease. She has recently completed a collaborative project to study the effects of light deprivation for the European Space Agency. She will host the International Pupil Colloquium in Switzerland in September 2017.



Keynote Lecture 1

Dr. Carol Shields completed her residency in ophthalmology at Wills Eye Hospital in Philadelphia in 1987 and subsequently did fellowship training in ocular oncology, oculoplastic surgery, and ophthalmic pathology. She is currently Co-Director of the Oncology Service, Wills Eye Hospital, and Professor of Ophthalmology at Thomas Jefferson University in Philadelphia.

She has authored or coauthored 12 textbooks, over 1500 articles in major peer-reviewed journals, over 300 textbook chapters, given over 700 lectureships, and has received numerous professional awards. 

Read more.



Keynote Lecture 2

Shomi Bhattacharya graduated in Chemistry from University of Mumbai in 1969 and then came to UK in 1970. He completed his M.Sc. in 1971 followed by Ph.D. from University of Newcastle upon Tyne in 1977. In 1980 he joined University of Edinburgh where in 1984 identified the first genetic locus for retinitis pigmentosa (RP). In 1986 he started his own research group and in 1987 he returned to Newcastle where he was appointed as head of Molecular Genetics in the department of Human Genetics.

Read more.



Caroline KLAVER
Keynote Lecture 3

Caroline Klaver is professor of epidemiology and genetics of eye diseases at Erasmus MC Rotterdam. She is a retinal specialist who trained as a fellow at University of Iowa and at Columbia University and at  Vitreous-Retina-Macula Consultants in New York and currently has her clinic at Radboud UMC, Nijmegen. Her research focuses on genetic-epidemiologic studies of various complex (myopia, age-related macular degeneration (AMD), glaucoma) and Mendelian eye disorders (retinal dystrophies). She is the principal investigator of ophthalmologic studies in 7 large epidemiologic cohorts from Rotterdam. Recently, her interest has shifted towards functional studies as her ultimate ambition is to find targets for intervention and diminish patient load.



EVER-Acta Lecture

Prof Schmetterer is Professor of Ophthalmology and head of ocular imaging at Singapore Eye Research Institute. His interests span a wide range of ocular imaging from development of novel technologies to applications in preclincal research and clinical settings. Prof Schmetterer is also interested in clinical trials and is involved in many studies in retina, glaucoma, cornea and dry eye. He has published more than 280 peer reviewed publications, was invited for more than 200 lectures including more than 15 keynote lectures and has been awarded more than 15 million Euro in research grant funding. He is a member of the Editorial Boards of Acta Ophthalmologica, Journal of Ocular Pharmacology and Therapeutics, Current Eye Research and five other journals.

Read more.



Hendrik SCHOLL
Ophthalmic Research Lecture

Hendrik P.N. Scholl, M.D., M.A. is Professor and Chairman of the Department of Ophthalmology, University of Basel, and Adjunct Professor of Ophthalmology at the Wilmer Eye Institute, Johns Hopkins University. He received his M.D. from the Eberhard Karls University of Tuebingen, Germany, and did his residency at the Centre for Ophthalmology, University of Tuebingen. He did a clinical research fellowship at Moorfields Eye Hospital, London, UK. In 2004, he was awarded a Heisenberg-Fellowship of the German Research Foundation for his achievements in the field of macular degeneration and subsequently joined the faculty at the Dept. of Ophthalmology, University of Bonn for 5 years until he was recruited to the Wilmer Eye Institute in 2010 where was leading the retinal degeneration clinic and the Visual Neurophysiology Service of the Johns Hopkins Hospital until 2016. Read more.



European Ophthalmic Heritage Lecture

Alan C. Bird, Chief Scientist for The MacTel Project, is a Professor and Consultant at the Institute of Ophthalmology at the Moorfields Eye Hospital in London, UK. Since joining Moorfields in 1969, Dr. Bird has held numerous positions. For the past several years, Dr. Bird’s his main area of interest is retina. Under his direction, The Medical Retinal Service now holds 24 clinics each week, and has 7 Consultants. A productive multidisciplinary research team developed for the investigation of monogenic retinal disorders and age-related macular disease. Investigative techniques included molecular genetics, electrophysiology, psychophysics, specialised imaging and morphology. Along with his colleagues, Dr. Bird as established research programs in inflammatory eye disease, and retinal vascular diseases. Dr. Bird has done extensive international work in Africa on river blindness and in Jamaica on retinal changes in sickle cell disease. Dr. Bird has received a number of awards in recognition of his work.